Developments in US Antitrust Litigation—2020 Year in Review
Arnold Porter
JUNE 2, 2021
1036 (2016), that the standard for predominance is satisfied "unless no reasonable juror could believe the common proof at trial."[[N: and its subsidiary, AbbVie Biotechnology, Ltd. On April 7, 2020, the District of Delaware rejected DOJ's bid to block Sabre's acquisition of Farelogix, a travel technology company.[[N:
Let's personalize your content